CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 385 enrolled
Drug / intervention
Medtronic Adapta Dual Chamber Pacemakerdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01039467
NCT01039467N/ACompleted
CompareCT.gov

Study of a Comparison of the Pacemaker Automatic Features in Reduction of Ventricular Pacing

Medtronic Cardiac Rhythm and Heart Failure·interventional·Posted Dec 25, 2009·Updated Feb 5, 2020

In Brief

A clinical study evaluating Medtronic Adapta Dual Chamber Pacemaker for Bradycardia. Completed, enrolled 385 participants across 30 sites.

Detailed Summary

The COMPARE-Adapta study is a randomized, multi-center, prospective study conducted in China. The purpose of the study is to compare the ability of Search AV™+ and Managed Ventricular Pacing® (MVP®) to reduce ventricular pacing in dual chamber pacemaker-indicated patients. The COMPARE-Adapta study will also observe atrial fibrillation (AF) burden as demonstrated by Cardiac Compass® and the clinical profile Adapta® pacemaker patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBradycardia
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 25, 2009
Enrollment StartJun 1, 2009
Primary CompletionApr 1, 2014
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 16.5 years ago

Interventions

Medtronic Adapta Dual Chamber Pacemakerdevice

Medtronic Adapta Dual Chamber Pacemaker